Megan S. McAfee

2011-2015 Molecular and Cellular Biology Arizona State University, Tempe, AZ, United States 
"Megan McAfee"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chapuis AG, Egan DN, Bar M, et al. (2019) T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant. Nature Medicine
Holechek SA, McAfee MS, Nieves LM, et al. (2016) Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination. Vaccine
McAfee MS, Huynh TP, Johnson JL, et al. (2015) Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity. Virology. 484: 153-162
Lussier DM, O'Neill L, Nieves LM, et al. (2015) Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions. Journal of Immunotherapy (Hagerstown, Md. : 1997). 38: 96-106
Stromnes IM, Fowler C, Casamina CC, et al. (2012) Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo. Journal of Immunology (Baltimore, Md. : 1950). 189: 1812-25
McAfee MS, Blattman JN. (2012) Combating chronic T-cell exhaustion. Immunotherapy. 4: 557-60
Johnson PL, Kochin BF, McAfee MS, et al. (2011) Vaccination alters the balance between protective immunity, exhaustion, escape, and death in chronic infections. Journal of Virology. 85: 5565-70
See more...